Analysis of the Clinical Effect of Pulmicort Respules Inhalation Combined with Cetirizine in the Treatment of Pediatric Asthma and its Influence on Inflammatory Factors in Children  

作　　者：Yong Peng Aimin Li 

机构地区：[1]Jingzhou Hospital Affiliated to Yangtze University,Jingzhou 434020,Hubei,China

出　　处：《Proceedings of Anticancer Research》2025年第2期71-76,共6页抗癌研究

摘　　要：Objective:To analyze the clinical value of Pulmicort Respules inhalation combined with cetirizine in the treatment of pediatric asthma.Methods:From December 2023 to December 2024,82 children with asthma admitted to our hospital were randomly divided into a control group and an observation group,with 41 cases in each group.The clinical symptom relief time(shortness of breath,cough,dyspnea,lung wheezing),lung function indicators(FEV1,FVC,FEV1/FVC),inflammatory indicators(TNF-α,IL-6,IL-8),and clinical treatment effects were analyzed in the two groups.Results:The relief time for shortness of breath,cough,dyspnea,and lung wheezing in the observation group was shorter than that in the control group(P<0.05).After treatment,compared with the control group,the levels of FEV1,FVC,FEV1/FVC,and treatment efficiency in the observation group were higher,while the levels of TNF-α,IL-6,and IL-8 were lower(P<0.05).Conclusion:The combination of Pulmicort Respules inhalation and cetirizine oral therapy for children with asthma can shorten the improvement time of clinical symptoms,inhibit inflammation,and improve lung function.

关 键 词：Pulmicort Respules CETIRIZINE Pediatric asthma Inflammatory factors 

分 类 号：R725.6[医药卫生—儿科]